Cost comparison of XELOX compared to FOLFOX4 with or without bevacizumab (bev) in metastatic colorectal cancer Meeting Abstract


Authors: Garrison, L.; Cassidy, J.; Saleh, M.; Lee, F.; Mena, R.; Fuloria, J.; Chang, V.; Ervin, T.; Stella, P.; Saltz, L.
Abstract Title: Cost comparison of XELOX compared to FOLFOX4 with or without bevacizumab (bev) in metastatic colorectal cancer
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-19
Start Page: 182s
Language: English
ACCESSION: WOS:000455043700728
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.4074
Notes: Meeting Abstract: 4074 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz